Research location
Edgbaston
Birmingham, United Kingdom
Advertisement
Research activity in Edgbaston
Birmingham, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Edgbaston
10 linked trials · page 1 of 1A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's DiseaseNCT03823404 · 2019-03-28 · 1 site observation
COMPLETED
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's SyndromeNCT02291029 · 2014-10-22 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.NCT01597297 · 2012-08-01 · 1 site observation
COMPLETED
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple SclerosisNCT01416181 · 2011-09-13 · 1 site observation
TERMINATED
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerNCT01101438 · 2010-08-13 · 1 site observation
COMPLETED
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerNCT00686959 · 2008-09-01 · 1 site observation
COMPLETED
Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation
COMPLETED
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV EventsNCT00327418 · 1997-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.